Form 4 for NKTR NEKTAR THERAPEUTICS
Accepted 2021-09-17 00:00:00 ET · period of report 2021-09-16 · accession 0001209191-21-056728 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-17 | 2021-09-16 | NKTR | WHITFIELD ROY A | Dir | M - OptEx | $13.80 | +40.0K | 225.8K | +22% | +$552.0K |
| D | 2021-09-17 | 2021-09-16 | NKTR | WHITFIELD ROY A | Dir | M - OptEx | $0.00 | -40.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-16 | M | A | 40,000 | $13.80 | 225,850 | D | — | — | |
| 2 | Derivative | Stock Option | 2021-09-16 | M | D | 40,000 | $0.00 | 0 | D | $13.80 · 2014-09-30 to 2021-09-18 | 40,000 Common Stock |